COMMUNIQUÉS West-GlobeNewswire

Transactions in connection with share buy-back program
05/05/2026
Company announcement no. 13 - 26 5 May 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
05/05/2026
ZUG, Switzerland, May 05, 2026 (GLOBE NEWSWIRE) -- Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention in diabetic macular edema (DME) management [...]
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
05/05/2026
MINNEAPOLIS and BRISBANE, Australia, May 05, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, [...]
Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
05/05/2026
Expands use of Nociscan in groundbreaking trial with Roger Härtl, MD BROOMFIELD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare [...]
Fortrea Reports First Quarter 2026 Results
05/05/2026
Strong first-quarter performance reinforces confidence in FY 2026 guidance Book-to-bill of 1.15x is third consecutive quarter above 1.1x Highlights For the three months ended March 31, 2026: Revenues of $636.5 million [...]
Integra LifeSciences Announces Leadership Transition
05/05/2026
Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings [...]
De nouvelles données de l’ACD révèlent un décalage entre la conscience de la génération Z des risques liés au bronzage et ses habitudes de protection solaire
05/05/2026
Près de 4 Canadiens sur 10 de la génération Z continuent de se faire bronzer malgré leur connaissance des risques associés OTTAWA, Ontario, 05 mai 2026 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) [...]
New CDA Data Reveals Disconnect Between Knowing the Risks of Tanning and Behaviour Among Gen Z
05/05/2026
Nearly 4 in 10 Gen Z Canadians Still Tan Despite Knowing the Risks OTTAWA, Ontario, May 05, 2026 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) launches its annual Sun Awareness Month campaign with a [...]
Poil-itiquement é-patte-tant : Le vote est ouvert pour le quatrième concours annuel « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
05/05/2026
Nombre record de 142 participants, plus de finalistes et une toute nouvelle catégorie « L’animal le plus élégant » font passer le concours à de nouveaux sommets OTTAWA, Ontario, 05 mai 2026 (GLOBE NEWSWIRE) -- L’ [...]
Paws-itively Paw-litical: Voting Opens for 4th Annual Cutest Pets on Parliament Hill
05/05/2026
Record-breaking 142 entries, expanded finalists, and a brand-new “Best Dressed Pet” category bring the cuteness campaign to new heights OTTAWA, Ontario, May 05, 2026 (GLOBE NEWSWIRE) -- The Canadian Animal Health [...]
Integra LifeSciences Reports First Quarter 2026 Financial Results
05/05/2026
PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending [...]
Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer
05/05/2026
WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Diagonal Therapeutics , a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, today [...]
Novo Nordisk A/S - share repurchase programme
05/05/2026
Bagsværd, Denmark, 5 May 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
05/05/2026
Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers Squibb Oncology pipeline strength and combination strategy highlighted through multiple clinical data updates, [...]
Santhera Publishes Agenda for its Annual General Meeting
05/05/2026
Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, May 5, 2026 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 26, [...]
Interim report Q1 2026
05/05/2026
Strong start to the year with 7% organic sales growth and 37.8% adjusted EBITDA margin Ester Baiget, President & CEO: ” The year started strong with 7% organic sales growth against a high comparable. We delivered [...]
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
05/05/2026
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares Cash runway remains into Q4 2027, supporting continued funding of clinical programs and pre- [...]
Transplantation d’organes : ALS obtient le marquage CE pour PERLA®, une nouvelle classe de solution - PPS - et lance une étude clinique comparative
05/05/2026
COMMUNIQUÉ DE PRESSE Transplantation d’organes : ALS obtient le marquage CE pour PERLA®, une nouvelle classe de solution - PPS - et lance une étude clinique comparative Obtention du marquage CE pour PERLA®, Solution de [...]
Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT)
05/05/2026
Press Release Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT) ALS has received CE marking approval for PERLA [...]

Pages